fbpx Back to Top

Renal Cell Carcinoma

Get Help with Your Treatment

Apply Online or call 1-866-316-7263


Program Status

Open - We are accepting applications for new and renewal patients. If your application for assistance is approved you can begin receiving funding immediately.


Assistance Amount

$5,900 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for renal cell carcinoma.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below  500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Adriamycin (doxorubicin hcl)
  • Afinitor (everolimus)
  • Avastin (bevacizumab)
  • Cabometyx (cabozantinib s-malate)
  • Carboplatin (carboplatin)
  • Cisplatin (cisplatin)
  • Doxorubicin Hcl (doxorubicin hcl)
  • Gemcitabine Hcl (gemcitabine hcl)
  • Gemzar (gemcitabine hcl)
  • Inlyta (axitinib)
  • Intron A (interferon alfa-2b,recomb.)
  • Lenvima (lenvatinib mesylate)
  • Nexavar (sorafenib tosylate)
  • Opdivo (nivolumab)
  • Paclitaxel (paclitaxel)
  • Prednisone (prednisone)
  • Proleukin (aldesleukin)
  • Sutent (sunitinib malate)
  • Tarceva (erlotinib hcl)
  • Torisel (temsirolimus)
  • Votrient (pazopanib hcl)
  • Yervoy (ipilimumab)
  • Zortress (everolimus)

Diagnosis Codes:

ICD-10: C64.1, C64.2, C64.9, C65.1, C65.2, C65.9